lobbying_activities: 1583936

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1583936	b3854a68-78d6-4030-949c-eec6dd624f6f	Q3	CALIFORNIA LIFE SCIENCES	7758	CALIFORNIA LIFE SCIENCES	2014	third_quarter	MMM	Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs, and 2015 Hospital Outpatient Prospective Payment System. Address concerns with Medicaid coverage of specialty drugs. Support creation of incentives for antibiotics development. Oppose changes to Medicare Advantage and Part D prescription drug benefit.Support Treat and Reduce Obesity Act.	HOUSE OF REPRESENTATIVES,SENATE		150000	0	0	2014-10-10T12:58:46.237000-04:00